Anxiety and Calm: The Honest Peptide Lever

The honest version of the peptide-for-anxiety story is short: Selank has the cleanest case - a Russian approved drug for generalised anxiety disorder with a 25-year clinical history, non-sedating, non-addictive, no withdrawal. Semax sits adjacent for users where the goal is "calm cognition" rather than pure anxiety reduction. Everything else marketed in this space is either off-target, speculative, or not a peptide.

The bigger honest point: peptides are a marginal lever for anxiety. Sleep hygiene, cardiovascular fitness, caffeine discipline, social structure, and whether you exercise are all higher-leverage. None of the compounds on this page rescues a structurally anxious life. They smooth the edges for someone who's already done the foundation work, or they buy a few hours of relief for a specific situation. That's the real frame.

The shortlist by goal

Selank - the load-bearing piece

What it is. A 7-amino-acid synthetic analogue of tuftsin, developed at the Russian Academy of Sciences' Institute of Molecular Genetics. Approved in Russia for generalised anxiety disorder; research-chemical status everywhere else.
Mechanism. Allosteric modulation of GABA(A) receptors (calming without direct agonism), enkephalin stabilisation (mood / pain perception), BDNF upregulation (neuroplasticity). The mechanism explains why the effect is calm-without-sedation rather than benzo-style cognitive flatness.
Evidence framing. Tier: Clinical for the Russian indications (Kozlovskaia 2003, Uchakina 2008 - small RCTs comparable to medazepam without sedation). Tier: Limited data for healthy-adult anxiolytic use specifically. Real responder population; the reported effect is consistent enough that placebo-only is implausible as the full story.
Protocol. 0.15% intranasal solution, 200–300 mcg (1–2 sprays per nostril), as needed before situational triggers OR daily morning for a smoother baseline. Onset 5–15 minutes; duration 2–4 hours per dose.
Why it's different from a benzo. No tolerance buildup over weeks, no withdrawal on discontinuation, no rebound anxiety after stopping. The downside is the duration - it doesn't carry an evening dose through to morning the way a long-acting benzo would.

Semax - when the goal is calm cognition

What it is. A 7-amino-acid ACTH(4-7) analogue from the same Russian research line as Selank. Approved in Russia for stroke and cognitive impairment indications.
Why it's adjacent here. Semax isn't an anxiolytic proper - it's primarily a cognitive enhancer with BDNF / NGF upregulation. But for users whose anxiety presents as rumination-and-cognitive-loop rather than physical-tension, Semax can smooth the loop in a way that feels anxiolytic. Different mechanism, overlapping outcome for a subset of users.
Protocol. 0.1% intranasal solution, 200–600 mcg morning. The "calm focus" stack (Stack 2 below) pairs Semax with Selank for users where neither works alone but the combination does.
What it doesn't do. Pure physical-anxiety presentations (palpitations, panic-attack pattern, somatic tension) - Semax is the wrong tool. Selank fits that case better.

What's NOT in the stack and why

DSIP. Sleep-onset peptide. Indirect anxiety effect via sleep quality, but not anxiolytic on the day-to-day timescale. See Sleep and Recovery if sleep is the actual driver.
Oxytocin. Bonding / social signal, not a generalised anxiolytic. Marketed for anxiety in some grey-market spaces; the case is weaker than Selank's by an order of magnitude.
BPC-157 oral for "gut-brain anxiety." The gut-brain axis is real; the BPC-as-anxiolytic case is a stretch. If gut inflammation is the actual driver, treat the gut directly - see Gut Health.
Kava, ashwagandha, magnesium glycinate. Not peptides; out of scope for this catalogue. Mentioned because they get conflated with peptide protocols. They have their own evidence; this page isn't the place for that comparison.

Decision guide

Have you actually fixed sleep, cardio, caffeine, and social structure?
→ If not, fix that first. Selank doesn't rescue 5h of sleep on 300 mg of caffeine. Cardio 3x/week and a 2 PM caffeine cutoff have higher signal than any compound on this page.
Is the limiter situational or structural?
→ Situational (presentations, travel, social events) → Selank as needed.
→ Structural (chronic, daily) → Selank daily morning OR a real clinical evaluation. Peptides are the marginal lever, not a substitute for treatment if the structural anxiety is significant.
Is the presentation cognitive (rumination, looping) or somatic (tension, palpitations)?
→ Cognitive → Semax morning, optionally + Selank.
→ Somatic → Selank, not Semax.
On a benzodiazepine currently?
→ Don't stop the benzo to switch to Selank cold. Selank doesn't cross-cover benzo withdrawal; the kinetics are completely different. A taper plan is a clinical question, not a peptide swap.
Tested athlete?
→ Selank and Semax are non-approved Russian compounds, fall under WADA S0 catch-all. Not compatible with tested competition. See WADA Testing and Detection.

Representative stacks

Stack 1 - Situational Selank (default)

Selank 0.15% intranasal, 200–300 mcg 1–2 sprays per nostril, 15–30 minutes before the situational trigger
Refrigerate the spray between uses; check the label for opening-date rules (2–3 weeks once opened is typical)
Track response in a brief journal - note dose, situation, perceived effect 1–10. The signal is subtle enough that recall bias matters

Stack 2 - Calm focus / "Zen"

Semax 0.1% intranasal, 200–600 mcg morning
Selank 0.15% intranasal, 200–300 mcg with the Semax dose, OR as needed for daytime anxiety spikes
4-week trial period - if neither cognitive output nor anxiety smoothes in 4 weeks, stop. The protocol works fast for responders; long trials don't convert non-responders.

Stack 3 - Daily Selank baseline

Selank 0.15% intranasal, 200–300 mcg morning, daily
Reassess at 4 weeks - Selank works well as a tool, less well as a chronic baseline. If the structural anxiety isn't improving with the foundation work, this is a clinical conversation, not a dose-up conversation
Optional: situational top-up dose for specific high-stress events

What stops people

Skipping the foundation and expecting peptides to rescue. Most-common failure pattern. Selank on top of 4h of sleep + 400 mg of caffeine + a sedentary baseline is doing 5% of the work the foundation would do. Order matters.
Treating Selank as a benzo substitute mid-taper. The kinetics and receptor profile don't overlap enough. Selank doesn't cross-cover benzo withdrawal; trying to use it that way produces misleading "doesn't work" reports while a benzo taper is failing in parallel.
Storing Selank at room temperature. The intranasal sprays degrade at room temp within days. Spray that's been left out isn't half-effective; it's mostly inert. Refrigerate between uses.
Counterfeit Russian-original Selank. Innopharm is the reference brand. Most "Selank" sold in Western grey markets is research-grade peptide reconstituted by the vendor - not the same as the Russian pharmacy product. The community-log signal is real but sourcing variance is the biggest source of "doesn't work" reports. See Sourcing and Verification.
Continuous baseline use blunting the situational benefit. This is real but uncommon - for most users, daily Selank stays effective. If you notice the situational top-up dose stops working as well, drop the daily for 2 weeks; the situational responsiveness usually returns.

Monitoring

Anxiety scale (GAD-7). Free, takes 60 seconds, run weekly. The cleanest objective signal for these compounds. Cognitive bias is real here; written records beat impression.
Subjective journal. Daily 1–10 rating of mood, anxiety, sleep, energy. Track alongside dose timing and any situational use.
Resting heart rate. Anxious users often run elevated RHR; trends downward as anxiety smoothes. Wearable-grade signal is enough.
Sleep tracker if available. Anxiety and sleep are bidirectional; improvements in one usually appear in the other.
No specific bloodwork required. Selank and Semax don't move standard panel markers in any concerning way.

Cross-references

Selank peptide page - mechanism, dosing, evidence, references.
Semax peptide page - adjacent cognitive-focus tool.
Cognitive Focus application - for users where focus / output is the primary goal and anxiety smoothing is secondary.
Sleep and Recovery application - for users whose anxiety is downstream of sleep problems (a meaningful subset).
Sourcing and Verification - particularly load-bearing for the Russian research compounds.